MedTrace Logo

Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

NCT06071377 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-11-06

No results posted yet for this study

Summary

The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.

Conditions

  • Sickle Cell Trait

Interventions

OTHER

Biologic Specimen Collection

Participants will have blood and urine collected at Baseline

Sponsors & Collaborators

  • Beam Therapeutics Inc.

    collaborator INDUSTRY

  • National Alliance for Sickle Cell Centers

    lead OTHER

Principal Investigators

  • Julie Kanter, MD · National Alliance for Sickle Cell Centers

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2026-12-31
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06071377 on ClinicalTrials.gov